Persistence and adherence to parenteral osteoporosis therapies: a systematic review

Osteoporosis is a chronic disease of low bone mass and fragility. Treatment is frequently compromised by suboptimal medication compliance causing increased morbidity. This review investigates adherence and persistence to parenteral osteoporosis therapies. Findings reveal parenteral medications requiring reduced dosing frequency have higher compliance than oral therapies. This systematic review examines real-world adherence to parenteral osteoporosis therapies. We searched PubMed, Medline, and EMBASE databases for English language observational studies that examined patient adherence and/or persistence to parenteral osteoporosis treatments (teriparatide sc, ibandronate iv, zoledronic acid iv, and denosumab sc) in adults with osteoporosis published up to September 2018. Studies with only self-reported adherence or persistence data and those with less than 20 patients were excluded. Quality assessment of included studies was completed using the Newcastle-Ottawa quality assessment scale (NOS). We identified 40 eligible studies. Teriparatide was examined in 29 studies, with persistence rates of 10-87% (median 55%) at 1 year and 10-69% (median 29.5%) at 2 years, and adherence rates of 21-89% (median 53%) at 1 year and 37-68% (median 40%) at 2 years. Ten studies of zoledronic acid reported persistence rates of 34-73% (median 42%) for second dose and 20-54% (median 35.8%) for third dose. Ten studies of ibandronate adherence reported and 2-year persistence rates of 31-58% (median 47.5%) in 1 year and 13-35% (median 25%) at 2 years, and adherence rates of 21-72% (median 47.3%) and 15-58% (median 36.5%) respectively. Denosumab was reported in 19 studies, with second (1 year) and fourth (2 year) dose persistence rates of 61-100% (median 81%) and 36-99% (median 45.5%). There is substantial heterogeneity in reports of persistence and adherence rates with parenteral osteoporosis therapies. Most of the published data are from short-term studies and evaluations of long-term adherence and persistence with parenteral therapies for osteoporosis are needed.

Sol–gel synthesis and solar photocatalytic activity of Ca-alloyed ZnO nanoparticles elaborated using different precursors

Ca-alloyed ZnO nanoparticles elaborated using different calcium precursors (CaSO₄, CaCl₂, Ca(NO₃)₂ and CaCO₃) at different [Ca]/[Zn] ratios (0, 1, 5, 10, 15 and 20%) have been prepared by a sol–gel method followed by supercritical drying and annealing at 300 °C. The synthesized samples have been characterized by a number of techniques including Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), Energy Dispersive X-ray Spectroscopy (EDS), X-ray Diffraction (XRD), Raman Spectroscopy and Electron Paramagnetic Resonance (EPR). SEM and TEM images reveal that the nanoparticles have a quasi-spherical shape with a grain size between 20 and 40 nm. The EDS results on chemical elementary compositions show that the Ca-alloyed ZnO with a CaCO₃ precursor and [Ca]/[Zn] ratios of 5 and 10% are quasi-stoichiometric. The XRD results indicate that all the elaborated nanoparticles have a hexagonal wurtzite structure. Using Raman Spectroscopy a supplementary vibrational mode is detected in the case of CaSO₄, CaCO₃ and Ca(NO₃)₂ precursors. The intrinsic defect centers and defect number have been studied using EPR. Two intrinsic defects with different g factors are identified by EPR for which the spectral intensities change with calcium precursors. Furthermore, EPR reveals a correlation between the defect number and photocatalytic efficiency. The photocatalytic efficiency of the nanoparticles elaborated with different precursors and compositions has been studied for the solar photocatalytic degradation of pyrimethanil, using a solar simulator. The results show that the nanoparticles of Ca-alloyed ZnO elaborated with a CaCO₃ precursor give promising results and enhance the photocatalytic efficiency in the solar field.

Schematic representation of core–shell intrinsic defects in Zn_1−xCa_xO nanoparticles observed by EPR spectroscopy.

In situ synthesis of gold nanoparticles in polymer films under concentrated sunlight: control of nanoparticle size and shape with solar flux

We proposed a one step, green and efficient approach to synthesize plasmonic nanocomposites over large surfaces and with controlled morphologies.

Use of solar advanced oxidation processes for wastewater treatment: Follow-up on degradation products, acute toxicity, genotoxicity and estrogenicity

Wastewater tertiary treatment by advanced oxidation processes is thought to produce a treated effluent with lower toxicity than the initial influent. Here we performed tertiary treatment of a secondary effluent collected from a Waste Water Treatment Plant via homogeneous (solar/HSO5(-)/Fe(2+)) and heterogeneous (solar/TiO2) solar advanced oxidation aiming at the assessment of their effectiveness in terms of contaminants' and toxicity abatement in a plain solar reactor. A total of 53 organic contaminants were qualitatively identified by liquid chromatography coupled to high-resolution mass spectrometry after solid phase extraction. Solar advanced oxidation totally or partially removed the major part of contaminants detected within 4.5 h. Standard toxicity tests were performed using Vibrio fischeri, Daphnia magna, Pseudokirchneriella subcapitata and Brachionus calyciflorus organisms to evaluate acute and chronic toxicity in the secondary or tertiary effluents, and the EC50% was calculated. Estrogenic and genotoxic tests were carried out in an attempt to obtain an even sharper evaluation of potential hazardous effects due to micropollutants or their degradation by-products in wastewater. Genotoxic effects were not detected in effluent before or after treatment. However, we observed relevant estrogenic activity due to the high sensitivity of the HELN ERα cell line.